) has introduced a new range of HOWARU Protect probiotics that
are clinically documented to keep natural immune defenses. The
three formulations - HOWARU Protect Kids, HOWARU Protect Adult
and HOWARU Protect Sport - are for children, adults and sports
HOWARU Protect formulations are clinically tested and proven to
deliver the required immune support. HOWARU Protect products are
available to dietary supplement, diary, food and beverage makers.
DuPont's HOWARU Protect Kids helps to keep children healthy in
the winter season by supporting their respiratory health immune
avoid catching cold and flu. A research work published in
Pediatrics also showed that HOWARU Protect Kids supported
respiratory health with symptom duration shortened from 6.5 to
3.5 days, resulting in reduction of antibiotic use and number of
HOWARU Protect Adult probiotics helps to maintain healthy
respiratory function in adults. According to the study published
in Clinical Nutrition, HOWARU Protect Adult has reduced the risk
of upper respiratory tract illness by 27% along with a delay of
onset of respiratory tract illness.
HOWARU Protect Sport probiotics aids the physically active adults
to remain healthy for optimal sports performance by increasing
the level of physical activity,; extending duration of
exercises,; improving training intensity and delaying the onset
of respiratory infections.
DuPont's probiotics business is growing fast as customers are
increasingly benefiting from their products. DuPont is expected
to gain significant position in the probiotics market as the
global retail market for probiotics is estimated at $32 billion
in 2013 and $45 billion in 2018.
As per the World Health Organization, probiotics are 'live
micro-organisms' that confer digestive and immune health benefits
to the in taker when consumed in adequate amounts.
DuPont posted its third-quarter 2013 results on Oct 22. The
company's adjusted earnings of 45 cents per share in the quarter
beat the Zacks Consensus Estimate by 4 cents. The adjusted
earnings exclude one-time items including charges associated with
customer claims related to the use of an herbicide and
Net sales for the reported quarter rose roughly 5% year over year
to $7,735 million, but missed the Zacks Consensus Estimate of
$7,774 million. Including other income, total revenues were
$7,805 million. The year-over-year increase was also backed by
strength in the agricultural business that saw a double-digit
rise in sales.
DuPont backed its full-year 2013 earnings outlook and continues
to expect adjusted earnings per share of roughly $3.85. While
DuPont sees overall growth in industrial market demand to remain
subdued sequentially in the fourth quarter, it expects operating
earnings to be considerably higher from the last year. Despite
the weakness in its Performance Chemicals segment, the company is
optimistic to deliver modest earnings growth for the full
DuPont currently carries a Zacks Rank #3 (Hold).
Other companies in the chemical industry worth considering are
Asahi Kasei Corp.
). While both Asahi Kasei and Methanex carry a Zacks Rank #1
(Strong Buy), PPG Industries retains a Zacks Rank #2 (Buy).
ASAHI KASEI CP (AHKSY): Get Free Report
DU PONT (EI) DE (DD): Free Stock Analysis
METHANEX CORP (MEOH): Free Stock Analysis
PPG INDS INC (PPG): Free Stock Analysis
To read this article on Zacks.com click here.